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A B S T R A C T
Endometriosis is a condition wherein an ectopic layer of endometrial tissue arises in an extra-uterine location,
often effecting significant pelvic pain and infertility. While very uncommon, there have been reported cases of
endometriosis undergoing malignant transformation, frequently involving the ovaries and seldom in extra-go-
nadal regions. We recount a case depicting a 63 year-old woman who presented with an apparent inguinal hernia
in 2017; she was ultimately diagnosed with a pelvic side wall clear cell carcinoma and attendant metastatic
disease to the medial groin, which emanated from endometriosis. Malignant transformation of endometriosis
identified in the pelvic side wall is a very rare finding. Nevertheless, oncologists should maintain a high index of
suspicion in patients with a history of endometriosis or pelvic surgery.
1. Introduction
Endometriosis is characterized by the presence of ectopic en-
dometrial tissue. The condition, albeit benign, is often painful and a
source of infertility in nearly 10–15% of reproductive-aged women
(Kavoussi et al., 2016). Endometriosis originates from metaplasia of the
coelomic epithelium and has the potential to infiltrate distant areas via
hematogenous and lymphatic dissemination (Su et al., 2004).
Endometriosis has been identified in the ovaries, pelvis, cervix, labia
and vagina (Agarwal & Subramanian, 2010); alternatively, uncommon
implantation sites include the lung, bladder and within abdominal
surgery scars (Acién & Velasco, 2013; Bodner et al., 2003). In very rare
cases, the disease undergoes malignant transformation, with docu-
mented rates approximating 0.3% to 1.0% (Matter et al., 2003; Debus &
Schuhmacher, 2001). When this neoplastic process arises, the disease
typically is comprised of endometrioid or clear cell histology (Ruiz
et al., 2015; Bats et al., 2008).
Endometriosis has been described in patients with a history of gy-
necologic surgery, namely following a caesarean section (Horton et al.,
2008). Nevertheless, it is quite unusual to encounter a carcinoma ori-
ginating from endometriosis in the abdominal wall (Marques et al.,
2017; Taburiaux et al., 2015), let alone the pelvic side wall. Herein, we
review a patient with clear cell carcinoma of the pelvic side wall,
stemming from endometriosis.
2. Case report
A 63 year-old (gravida 1, para 1) woman initially presented with a
suspected left inguinal hernia in May 2017; The patient's medical his-
tory was significant for hypertension and hypercholesterolemia. The
initial herniorrhaphy was performed by a general surgeon who aborted
the procedure when he ascertained that the condition was not an in-
guinal hernia but instead, a malignant condition. During the attempt at
intraoperative repair, a necrotic, cancerous mass was encountered.
Following a review of histologic and imaging data, the lesion was
presumed to be ovarian cancer. The patient's preoperative CA-125 was
470 U/mL; she then commenced with neoadjuvant intravenous che-
motherapy encompassing paclitaxel (80mg/m2) on days 1, 8, and 15 of
a 21-day cycle and carboplatin (AUC 6) on day 1.
After the completion of two cycles of chemotherapy, the patient was
taken to the Operating Room and underwent an exploratory lapar-
otomy, total abdominal hysterectomy and bilateral salpingo-oophor-
ectomy, total omentectomy, bilateral pelvic lymph node dissection,
bilateral inguinal lymph node dissection, radical dissection of the left
inguinal ligament with radical tumor debulking and mesh reconstruc-
tion.
During an examination of the abdomen and pelvis, a 12×10 cm
cystic and solid left inguinal mass was identified, which extended
through the femoral canal into the abdominal cavity (Fig. 1). The entire
neoplasm was retroperitoneal, with visible, gross tumor at the distal
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iliac vessels and in the medial left inguinal space. There was evidence of
both left pelvic and inguinal lymphadenopathy; furthermore, a patho-
logically, enlarged right inguinal lymph node, measuring approxi-
mately 4 cm, was noted with an absence of pathologic right pelvic and
peri-aortic adenopathy.
The patient's appendix, small and large bowel were all palpably
normal. There was no visible evidence of endometriosis on the uterus or
ovaries. The left ovary was normal and adjacent to the large retro-
peritoneal pelvic and inguinal mass. The disease was noted to be den-
sely adherent to the external iliac vessels and fixed to the surrounding
tissue, with minimal mobility. An incision was made over the left groin
and approximately 300mL of dark bloody fluid was aspirated; there-
after, a large, solid and cystic mass in the medial groin incision was
visualized.
The lesion was dissected, mobilized externally and ultimately de-
livered through the femoral canal into the abdomen. The remaining
tumor and enlarged lymph nodes within the medial inguinal space were
also excised. A left pelvic lymph node dissection, resection of proximal
lymphatic tissue and removal of obturator nodes were also performed;
this procedure was repeated on the contralateral side. Subsequently, a
biologic mesh was inserted into the left pelvis, which was secured with
2–0 Vicryl and Tisseel. The right groin mass was completely excised;
The patient tolerated the procedure well and was admitted to the
Recovery Room in stable condition.
The final pathology revealed Stage IVB clear cell carcinoma arising
from endometriosis with a synchronous but apparently unrelated stage
IA endometrial adenocarcinoma (Fig. 2a–d). There were also 5 pelvic
lymph nodes positive for malignancy. The disease was confined to the
retroperitoneal/inguinal mass, bilateral inguinal nodes, and left pelvic
lymph nodes. The uterus, cervix, tubes, ovaries, and right pelvic nodes
were normal. Following a molecular biomarker evaluation, her tumor
was determined to be MSI stable, effectively precluding Lynch syn-
drome. Postoperatively, the patient was slated for radiotherapy and
completion of her chemotherapy regimen.
3. Conclusions
Endometriosis undergoing malignant transformation is an extremely
unusual finding. Sampson attributed this process to the disease's
proximity to the neoplasm, exclusion of an additional primary site of
malignancy, and the histologic appearance of endometrial stroma
contiguous with epithelial glands (Debus & Schuhmacher, 2001;
Sampson, 1925). Additionally, prolonged exposure to unopposed es-
trogen has been implicated (Agarwal & Subramanian, 2010; Debus &
Schuhmacher, 2001).
When endometriosis transitions to a malignant pathology, the ovary
is commonly involved (Agarwal & Subramanian, 2010). Conversely,
abdominal wall carcinoma arising from endometriosis is exceedingly
uncommon, with only 27 cases documented since 2014 (Taburiaux
et al., 2015). Carcinoma of the pelvic side wall originating from en-
dometriosis is seemingly more atypical, as we were only able to identify
two patients in the literature with this condition (Leiserowitz et al.,
2003).
In the current study, we review the history of a woman diagnosed
with clear cell carcinoma of the pelvic side wall with metastatic in-
volvement of the medial groin, stemming from endometriosis.
Endometriosis has been identified as a precursor of clear cell carci-
noma, which presumably accounts for the higher incidence of this
Fig. 1. Large complex solid and cystic mass that is arising from the left hemi-
pelvic sidewall, and extending to the inguinal region and skin surface.
Fig. 2. a) Representative histologic section of en-
dometrial lesion showing FIGO grade 1 en-
dometrioid-type adenocarcinoma with abundant
squamous morules (H&E; 40×); b) Focus of en-
dometriosis associated with pelvic side wall lesion (H
&E; 40×); c) Area of presumed endometriosis with
hemosiderin deposition in association with clear cell
carcinoma (arrows; H&E; 40×); d) High-power view
of clear cell carcinoma (pelvic side wall lesion) with
variable eosinophilic cytoplasm (eosinophilic variant
of clear cell carcinoma) (H&E; 400×).
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histologic subtype (Taburiaux et al., 2015). The precipitant of the
neoplastic event in the current study remains idiopathic, although one
may conjecture that genetics, immunological or hormonal factors were
contributing factors (Marques et al., 2017). We can ultimately preclude
the influence of estrogen therapy since the patient did not have a his-
tory of taking this medication.
The clinical management of clear cell carcinoma of the pelvic side
wall is indeterminate. Surgical treatment has reportedly been com-
prised of local resection, total abdominal hysterectomy or salpingo-
oophorectomy (Ijichi et al., 2014). In addition to definitive surgery, a
regimen of carboplatin and paclitaxel has been considered effective at
treating this malignancy (Marques et al., 2017). Radiotherapy has also
been reportedly beneficial in combination with platinum-based therapy
for the treatment of endometriosis related cases of malignant transfor-
mation (Mihailovici et al., 2017); moreover, radiotherapy is potentially
indicated when addressing metastatic disease (Macrie et al., 2014).
Unfortunately, once a patient exhibits disease recurrence, secondary
treatment is ostensibly ineffective (Ijichi et al., 2014).
When oncology physicians encounter primary and metastatic le-
sions in very unusual locations, they should consider the potential for
malignant endometriosis in the differential diagnosis, especially in pa-
tients who have a history of endometriosis, underwent gynecologic
surgery or were previously treated with hormone replacement therapy.
Despite the remote incidence of pelvic side wall carcinoma arising from
endometriosis, we recommend further study evaluating the optimal
method in which to diagnose and manage this complicated disease.
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